Shared Decision Making and Treatment Satisfaction in Japanese Patients with Inflammatory Bowel Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 454, doi. 10.1159/000471795
- By:
- Publication type:
- Article
Works matching IS 02572753 AND DT 2017 AND VI 35 AND IP 5
Results: 9
1
2
Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 478, doi. 10.1159/000471874
- By:
- Publication type:
- Article
3
Correlation of High-Resolution Manometric Findings with Symptoms of Dysphagia and Endoscopic Features in Adults with Eosinophilic Esophagitis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 472, doi. 10.1159/000458407
- By:
- Publication type:
- Article
4
An Analysis of Transcobalamin II Gene Polymorphisms and Serum Levels of Homocysteine, Folate and Vitamin B<sub>12</sub> in Chinese Patients with Crohn's Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 463, doi. 10.1159/000471848
- By:
- Publication type:
- Article
5
Benign Exocrine Pancreatic Diseases in Inflammatory Bowel Diseases.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 449, doi. 10.1159/000471481
- By:
- Publication type:
- Article
6
Intravenous Iron Replacement Improves Quality of Life in Hypoferritinemic Inflammatory Bowel Disease Patients with and without Anemia.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 444, doi. 10.1159/000468145
- By:
- Publication type:
- Article
7
Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol Gallstone.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 439, doi. 10.1159/000465517
- By:
- Publication type:
- Article
8
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 433, doi. 10.1159/000458722
- By:
- Publication type:
- Article
9
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 423, doi. 10.1159/000475494
- By:
- Publication type:
- Article